Regulatory Milestones and Health Advances: Key Developments in the Pharmaceutical Sector

In the latest updates on health news, the European Medicines Agency has recommended Novo Nordisk’s Wegovy for managing heart failure in obese individuals, marking its second supported use beyond weight loss. Novo’s case for the drug’s versatile health benefits grows stronger.Meanwhile, the U.S. Food and Drug Administration has greenlit Zevra Therapeutics’ drug for a rare, deadly genetic disorder, after years of efforts by the company. The FDA also approved AstraZeneca’s…
Read More…

Source: https://www.devdiscourse.com/article/health/3095657-regulatory-milestones-and-health-advances-key-developments-in-the-pharmaceutical-sector